Medical AI company Caption Health appoints new CEO

Medical AI company Caption Health has appointed Steve Cashman as its new CEO and president, effective April 14. 

The company is known for its AI-powered ultrasound solution, Caption AI, that enables users to capture high-quality images without lengthy training on the technology.

Caption Health raised $53 million in a Series B funding round in 2020, spearheaded by DCVC, with other contributions coming from Atlantic Bridge, Edwards Lifesciences and Khosla Venture. To date, the California-based company has raised nearly $61 million, according to TechCrunch.

Cashman comes to Caption Health from InTouch Health, where he served as chief commercial officer. InTouch was acquired by Teladoc last year. In his role with InTouch, Cashman oversaw domestic and global sales, product, marketing, customer service and clinical services. Under his leadership, the company saw 35% year-over-year growth in 2019.

He takes over from Caption Health Co-Founder Charles Cadieu, PhD, who is departing from the role to pursue other ventures. 

“I've spent the last decade bringing the provider closer to the patient through telehealth. Now, by incorporating ultrasound imaging earlier in the patient journey, we can continue to improve access to care and inform the care pathway," Cashman said in a statement. "It's not hard to imagine a future where Caption AI is in the hands of every healthcare professional, from physicians to APPs to nurses, wherever they deliver care. This technology makes deep, meaningful assessments of human health as routine as checking a patient's blood pressure—and I'm excited for any part I can play in bringing about that future."

In addition to Cashman’s appointment, Kilian Koepsell, PhD, the remaining co-founder and current chief technology officer, will take on a larger leadership role, helping to advance Caption Health's strategy for technological innovation.

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.